vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $20.2M, roughly 1.7× La Rosa Holdings Corp.). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -27.4%, a 86.2% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 39.5%).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

DTIL vs LRHC — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.7× larger
DTIL
$34.2M
$20.2M
LRHC
Growing faster (revenue YoY)
DTIL
DTIL
+5257.9% gap
DTIL
5261.1%
3.2%
LRHC
Higher net margin
DTIL
DTIL
86.2% more per $
DTIL
58.9%
-27.4%
LRHC
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
39.5%
DTIL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DTIL
DTIL
LRHC
LRHC
Revenue
$34.2M
$20.2M
Net Profit
$20.1M
$-5.5M
Gross Margin
8.4%
Operating Margin
36.6%
-24.7%
Net Margin
58.9%
-27.4%
Revenue YoY
5261.1%
3.2%
Net Profit YoY
213.5%
-125.7%
EPS (diluted)
$2.62
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
LRHC
LRHC
Q4 25
$34.2M
Q3 25
$13.0K
$20.2M
Q2 25
$18.0K
$23.2M
Q1 25
$29.0K
$17.5M
Q4 24
$638.0K
$17.7M
Q3 24
$576.0K
$19.6M
Q2 24
$49.9M
$19.1M
Q1 24
$17.6M
$13.1M
Net Profit
DTIL
DTIL
LRHC
LRHC
Q4 25
$20.1M
Q3 25
$-21.8M
$-5.5M
Q2 25
$-23.5M
$78.4M
Q1 25
$-20.6M
$-95.7M
Q4 24
$-5.1M
Q3 24
$-16.4M
$-2.5M
Q2 24
$32.7M
$-2.3M
Q1 24
$8.6M
$-4.6M
Gross Margin
DTIL
DTIL
LRHC
LRHC
Q4 25
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
Q4 24
8.9%
Q3 24
8.3%
Q2 24
8.3%
Q1 24
8.9%
Operating Margin
DTIL
DTIL
LRHC
LRHC
Q4 25
36.6%
Q3 25
-158976.9%
-24.7%
Q2 25
-121538.9%
-10.6%
Q1 25
-76248.3%
-26.7%
Q4 24
-17.1%
Q3 24
-3693.6%
-8.9%
Q2 24
48.4%
-9.7%
Q1 24
-23.8%
-35.0%
Net Margin
DTIL
DTIL
LRHC
LRHC
Q4 25
58.9%
Q3 25
-167476.9%
-27.4%
Q2 25
-130666.7%
337.8%
Q1 25
-70913.8%
-546.5%
Q4 24
-28.7%
Q3 24
-2851.6%
-12.5%
Q2 24
65.6%
-12.2%
Q1 24
48.8%
-35.1%
EPS (diluted)
DTIL
DTIL
LRHC
LRHC
Q4 25
$2.62
Q3 25
$-1.84
$-5.44
Q2 25
$-2.13
$15.25
Q1 25
$-2.21
$-5.86
Q4 24
$28.54
Q3 24
$-2.25
$-16.49
Q2 24
$4.67
$-12.49
Q1 24
$1.70
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$115.6M
$4.0M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$92.2M
$1.6M
Total Assets
$154.4M
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
LRHC
LRHC
Q4 25
$115.6M
Q3 25
$44.9M
$4.0M
Q2 25
$62.2M
$5.1M
Q1 25
$77.2M
$2.9M
Q4 24
$86.3M
$1.4M
Q3 24
$101.2M
$1.8M
Q2 24
$123.6M
$1.6M
Q1 24
$137.8M
$1.1M
Total Debt
DTIL
DTIL
LRHC
LRHC
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
DTIL
DTIL
LRHC
LRHC
Q4 25
$92.2M
Q3 25
$16.6M
$1.6M
Q2 25
$34.1M
$3.4M
Q1 25
$49.3M
$-87.5M
Q4 24
$56.4M
$2.6M
Q3 24
$64.9M
$5.0M
Q2 24
$74.7M
$4.7M
Q1 24
$37.2M
$5.6M
Total Assets
DTIL
DTIL
LRHC
LRHC
Q4 25
$154.4M
Q3 25
$93.5M
$21.7M
Q2 25
$108.9M
$22.9M
Q1 25
$124.4M
$21.0M
Q4 24
$136.4M
$19.4M
Q3 24
$153.3M
$19.7M
Q2 24
$165.8M
$18.7M
Q1 24
$184.7M
$16.3M
Debt / Equity
DTIL
DTIL
LRHC
LRHC
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
LRHC
LRHC
Operating Cash FlowLast quarter
$-11.3M
$-1.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
LRHC
LRHC
Q4 25
$-11.3M
Q3 25
$-15.3M
$-1.3M
Q2 25
$-20.3M
$-1.4M
Q1 25
$-19.1M
$-3.5M
Q4 24
$-58.4M
$-1.1M
Q3 24
$-5.9M
$-591.6K
Q2 24
$-14.9M
$-803.1K
Q1 24
$-19.0M
$-538.3K
Free Cash Flow
DTIL
DTIL
LRHC
LRHC
Q4 25
$-11.3M
Q3 25
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
DTIL
DTIL
LRHC
LRHC
Q4 25
-32.9%
Q3 25
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
DTIL
DTIL
LRHC
LRHC
Q4 25
0.1%
Q3 25
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
DTIL
DTIL
LRHC
LRHC
Q4 25
-0.56×
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTIL
DTIL

Segment breakdown not available.

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons